baber/WOPTO huggingface dataset:
Patent PT-1774938-E (PT)
Title: Disposable pants
Inventor: FUJIOKA MASARU
IPC: A61F5/44
Filed: 2005-08-12
Abstract: This invention provides disposable pants (1) usable as both pants and a diaper, which ensure excellent stretchability to facilitate raising/lowering when putting them on, and the like. The disposable pants (1) have functions of both pants and a diaper, and a left front abdominal part (2a) and a right front abdominal part (2b) can be expanded to the left and right by breaking left and right breaking parts (17a) (17b). The left front abdominal part (2a) and right front abdominal part (2b) are provided with adhesive pieces (22a) (22b) attached/detached to/from an adhesive part (23) of a central front abdominal part (2c). The ratio between a lateral dimension (X1) of the front abdominal section (2) in a stretched state and a lateral dimension (X2) between positions to which the left and right adhesive pieces (22a) (22b) are bonded, respectively, is set to fall within a range of 0.05   X2/X1   0.55, which ensures stretchability of the front abdominal section (2).
Patent PT-2122968-E (PT)
Title: Group access to ip multimedia subsystem service
Inventor: ELBURG JOHANNES VAN
IPC: H04L29/06
Filed: 2007-02-22
Abstract: A method of facilitating access to services of an IP Multimedia Subsystem network by user terminals and services located behind an access point to said network. The access point is associated with a subscription to the IP Multimedia Subsystem network. The method comprises including within an Implicit Registration Set defined for said subscription, a wildcarded Public User Identity, Service Identity, Public User Identity sub-domain representative of a range of Public User Identities, or Public Service Identity sub-domain representative of a range of Public Service Identities. At IP Multimedia Subsystem registration of said access point with the IP Multimedia Subsystem network, the Public User identities and Service Identities contained In the Implicit Registration Set are distributed to a Serving Call Session Control Function allocated to said access point and to a Proxy Call Session Control Function to which said access point is attached.
Patent PT-2011602-E (PT)
Title: Grinding machine
Inventor: HEESEMANN JUERGEN
IPC: B24B7/06
Filed: 2008-06-20
Abstract: The machine has a grinding unit including multiple grinding heads with grinding elements (8) rotating about a respective shaft. A drive roller device drives the grinding elements by a common electric motor (23). The drive roller device consists of a flexible frictional engagement or positive engagement assembly which is guided parallel to a transporting chain (1) about deflection rollers (22) and is formed with the shafts of the grinding elements for rotationally driving irrespective of the speed of transportation of the grinding elements.
Patent PT-1992819-E (PT)
Title: Piston stroke counting device
Inventor: DIVISI WALTER
IPC: F04B51/00
Filed: 2008-05-12
Abstract: The device (1) for counting the strokes of a piston (3) sliding within a cylinder (2) comprises a support (5) housing a magnet (6) which generates a magnetic field (7). The support (5) also houses a sensor (9) arranged to sense the magnetic field (7), such that the passage of the piston (3) into a position corresponding with the magnet (6) causes a disturbance in the magnetic field (7), which is sensed by the sensor (9), to indicate a stroke of the piston (3).
Patent PT-1982704-E (PT)
Title: New molecular target of neurotoxicity
Inventor: IKHLEF ALI AIT
IPC: C12Q1/6883
Filed: 2002-08-13
Abstract: Detecting excitotoxicity and neuronal stress in a subject comprises in vitro measurement of phosphodiesterase-4 (PDE4), particularly PDE4B, or detecting the presence of a mutant form of the mRNA for PDE4B, particularly a form that lacks all or part of the 3'-non-coding region. Independent claims are also included for the following: (1) Use of a compound (A) that inhibits or reduces expression or activity of PDE4B for treatment of neurodegenerative diseases; (2) Primers (B) containing 8-20 consecutive residues from the nucleotide region 2384-2869 of a murine PDE4B sequence (S1) or 2461-4068 of a human PDE4B sequence; and (3) Kits for analyzing expression of PDE4. ACTIVITY : Nootropic; Neuroprotective; Antiparkinsonian; Anticonvulsant; Cerebroprotective. Granular neurons from the cerebellum of rats were treated with N-methyl-D-aspartate (i) and serine or kainate (ii), to stimulate excititoxicity. When this treatment was carried out in presence of 50 M pentoxifylline, toxicity was reduced from about 40 to 20% in (i) and from about 30 to 10% in (ii). MECHANISM OF ACTION : Inhibiting expression or activity of PDE4B, which is present at elevated level in pathological nerve tissue.
Patent PT-2212065-E (PT)
Title: Manual razor with pivoting shaving head
Inventor: BODET HERVE
IPC: B26B21/44
Filed: 2008-10-21
Abstract: The invention relates to a manual razor including a shaving head (10) having a attached on a handle (20), pivoting means (11, 21) between the head (10) and the handle (20) so that the head (10) can move from a use position perpendicular to the handle (20) into a stowage position parallel to the handle. In order for the razor to be easily stored while occupying as little space as possible, the blade can be pivoted without touching the blade, using a rack (21) provided on a sliding button located on the handle (20), and a toothed wheel (11) connected to the head (10), wherein the toothed wheel (11) and the rack (21) are sized and arranged to be in mutual engagement.
Patent PT-2275158-E (PT)
Title: Medication injector apparatus
Inventor: ATTERBURY WILLIAM GODWIN
IPC: A61M5/31
Filed: 2002-05-08
Abstract: A medication injector apparatus such as an injection pen. The injection pen includes a resettable, cartridge plunger drive assembly including an axially floating nut, a cartridge plunger engaging screw, and a drive clutch movable with the nut and which when rotated causes the screw to screw through the nut. When a cartridge assembly is mounted to the pen base, the floating nut and drive clutch are shifted proximally such that the drive clutch is in torque transmitting engagement with a rotatable drive member of the pen, such that rotation of that drive member results in drive screw advancement through the nut in the distal direction. When the cartridge assembly is not mounted to the pen base, the floating nut and drive clutch are biased distally to disengage the drive clutch from torque transmitting engagement with the rotatable drive member and to thereby allow the drive screw to be reset proximally through the nut to a position more retracted within the pen base. The injection pen includes a doseable quantity identifier that uses a rotational matrix (500) and a sensor (502) for electrically sensing the arrangement of the dose setting mechanism of the pen, which identifier may be part of a therapeutic dose indicating system that utilizes a cartridge recognizer to recognize a concentration of medication so as to allow an automatic determination of a therapeutic dose. The injection pen further may include an assembly for selectively rotating a drive sleeve of the pen, which assembly has a dial that rotates out during dose setting and which translates in without rotation during dose injecting.
Patent PT-2275462-E (PT)
Title: Copolymer having at least one alkoxy- or hydroxy-polyalkylene glycol grafted function, and use thereof
Inventor: BURI MATTHIAS
IPC: C09D7/45
Filed: 2003-11-07
Abstract: The use of a weakly ionic, water-soluble copolymer (A) is claimed as brightness activator at any angle of vision (i.e. at an angle of 20-85 (preferably 45-75) [deg]), where (A) is derived from at least one ethylenically unsaturated monomer (I) on which at least one alkoxy- or hydroxy-polyalkylene glycol function is grafted. Independent claims are included for: (a) an agent for activating brightness as above, comprising at least one copolymer (A); (b) methods for dispersing or milling minerals (B) in aqueous suspension, using (A); (c) aqueous suspensions of dispersed or milled (B), which contain (A); (d) a method for producing bulk coating slurries, using (A); and (e) coating slurries, which contain (A).
Patent PT-623162-E (PT)
Inventor: GU CHU-JUN
IPC: F25B9/00
Filed: 1993-01-22
Abstract: A nonazeotropic working fluid medium for use in a thermodynamic cycle system, comprising a mixture of compounds and characterized in that one or more vaporization loss/replenishment cycles of each less than about 15% of the total weight of the medium and cumulative up to about 50% of the total weight of the medium result in a total decrease in the coefficient of performance of said medium of no more than about 5%, or a loss in electric power generating efficiency of not more than about 3 percent.
Patent PT-658596-E (PT)
Inventor: WONG PHILIP
IPC: A23L29/269
Filed: 1994-12-09
Abstract: Composition based on dust-free biopolymer with rapid hydration, containing a biopolymer and a surfactant in a quantity of the order of 0.1 to 3 %, preferably of the order of 0.1 to 1.5 % of the weight of the said composition. The biopolymer preferably consists of a xanthan gum or of a succinoglucan in the form of nonglobular and nonovoid particles. The said composition may be employed as thickening agent or suspending agent for the preparation of industrial, alimentary, cosmetic or pharmaceutical formulations.
Patent PT-679371-E (PT)
Inventor: YOUNG MICHAEL JOHN RADLEY
IPC: A61B17/00
Filed: 1995-04-10
Abstract: A plurality of spaced ultrasonic piezoelectric transducers (A to H), may be so fixed by means of a bandage (10) or the like to and around an afflicted area of a patient as to enable their sequential or interlaced excitation, whereby the afflicted area of the patient can be excited from different aspects, so that ultrasonic energy is not permitted to enter the body from any single point on a continuous-wave basis. Each transducer (A to H) delivers its ultrasonic energy via a body of material (14) having a wave impedance that substantially matches the wave impedance of human soft tissue, thereby avoiding or minimising the annoyance of a mismatched entry into the patient's body. The net result is for the patient to derive the therapeutic benefits of a moving applicator, without any physical displacement of one with respect to any other of the plural spaced transducers. <IMAGE>
Patent PT-852867-E (PT)
Inventor: GORETA LUCAS
IPC: H04W28/06
Filed: 1996-09-25
Abstract: Disclosed is a method enabling the generation, by means of voice frequencies, of a sequence of several characters and the high-speed transmission of these characters. This method comprises the step of the elimination, during transmission, of the blanks between two successive characters when these characters are distinct or are encoded distinctly.
Patent PT-855235-E (PT)
Inventor: REINER SAUER DR
IPC: B21D51/26
Filed: 1997-12-06
Abstract: The method involves combining two metal sheets rolled to their final thickness and of width equal to a multiple of half the circumference of a can. The sheets are laid one on the other and joined by several continuous weld seams along the sheet separated by half the circumference as they are moved continuously past a welding device with several weld heads. The welded sheets are cut longitudinally along the centre of each weld seam to produce several flat tubes, which can be rolled up for storage and/or transport. The unrolled tubes are cut across into sections of length equal to a can height and then spread to form a can body, esp. a cylindrical body.
Patent PT-894833-E (PT)
Title: Dry pigment product containing an agglomerated carbonate containing pigment
Inventor: WEITZEL HANS-JOACHIM
IPC: C09D17/00
Filed: 1998-07-28
Abstract: A slurry consisting of (A) 25-70 wt% agglomerated, carbonate-containing pigment with a particle size distribution in which 80-99 wt% are below 2 microns in size, 50-90 wt% are below 1 micron and 0-10 wt% are below 0.2 micron, a steepness factor (SF = ratio of diameter at 50 wt% to diameter at 20 wt%) of 1.5-2.0 and a porosity of 45-65%, (B) 0.1-1.0 wt% known or commercially available dispersant which prevents the agglomerated pigment breaking up again in the slurry and (C) water (to 100 wt%). Also claimed is a process for production of the slurry.
Patent PT-1009621-E (PT)
Inventor: GEEST ADRIANUS FRANCISCUS VAN
IPC: B29C67/00
Filed: 1998-05-12
Abstract: Method for producing a shaped body, which method comprises the following steps; (1) applying a layer of pulverulent material to a surface, (2) patternwise applying at least one liquid to the layer of pulverulent material, forming a layer of patternwise bound-together pulverulent material, (3) repeating steps (1) and (2) a predefined number of times, so that a number of successive layers of patternwise bound-together powder, is formed, the successive layers of bound-together pulverulent material together forming the shaped body, and (4) removing the unbound powder, in which the liquid comprises water and the pulverulent material comprises at least one component which forms a binder after contact with water in step (2).
Patent PT-1026937-E (PT)
Title: Lawn edging
Inventor: RUDOLPH SCOTT
IPC: A01G9/28
Filed: 1998-08-07
Abstract: A landscape edging system includes a horizontally elongate edging strip having opposing sides, a tab projecting from a side of the edging strip, and a vertically elongate stake. The tab includes a first portion which extends away from the side of the edging strip and a second portion which extends substantially in a longitudinal direction of the elongate edging strip in spaced relationship from a vertical plane generally defined by the side of the edging strip from which the tab projects. The elongate stake includes at least one edge portion having a thickness approximately equal to a distance between the vertical plane generally defined by the side of the edging strip from which the tab projects and the portion of the tab which extends in the direction of the elongate edging strip. The system allows opposing sides of the edge portions of the stake to be engaged by and retained between the edging strip and the tab. The arrangement allows greater flexibility in configuring a stake having a high strength for the amount of material being used to form the stake.
Patent IE-790107-L (IE)
Title: Substituted propanolamine and morpholine derivatives
IPC: C07C205/32
Filed: 1979-01-30
Abstract: Substituted morpholine derivatives, such as, for instance, the compound 2-[ alpha -(2-methoxy-phenoxy)-benzyl]-morpholine are disclosed. The claimed compounds are active on the central nervous system, and may be used as antidepressant agents.
Patent IE-890120-L (IE)
Title: Seven hole spinneret
IPC: D01D5/42
Filed: 1989-01-17
Abstract: Segmented spinning capillaries for post-coalescent spinning provide the capability to spin round cross-section filaments with round continuous voids along the length of the filaments by adding an inner arcuate slot (44) at the base of each spoke (43) of each slot segment (40).
[EP0352389A1]
Patent IE-790164-L (IE)
Title: Electrochemical cell
IPC: H01M4/58
Filed: 1979-01-30
Abstract: An electrical primary cell using lithium as its negative active material and whose positive active material includes thionyl chloride. The electrolyte of the cell is a solution including the thionyl chloride as a solvent. The solute is a complex salt resulting from the reaction of at least one of the following compounds with aluminum chloride: lithium oxide Li2O; lithium sulphide Li2S; calcium oxide CaO; and barium oxide BaO. (From US4228229 A) [GB2013390A]
Patent IE-880179-L (IE)
Title: Phospholipid delivery vehicle for aqueous-insoluble active¹ingredients
IPC: A61K9/133
Filed: 1988-01-25
Abstract: Compositions comprising phospholipid-encapsulated vesicles of active ingredient and triglyceride are described. In a preferred embodiment the vesicles are composed of a hexamethylmelamine active ingredient, with trilaurin or trimyristin as the triglyceride and a mixture of distearoylphosphatidylcholine, distearoylphosphatidylglycerol and cholesterol in the phospholipid outer layer. Preferably the molar ratios of active ingredient: triglyceride : DSPC : CHOL : DSPG will be from about 1:4:2:1:0 to about 1:4:1:1:1. Glycerol may be added to the carrier phase to reduce agglomeration. The composition may be used to deliver otherwise aqueous-insoluble agents to humans or animals to treat, for example, tumors.
Patent IE-800221-L (IE)
Title: Creatine kinase-mb determination.
IPC: G01N33/70
Filed: 1980-02-05
Abstract: A method for the determination of creatine kinase-MB in serum by immunological exclusion of sub-unit M and measurement of the sub-unit B for the determination of creatine kinase, the improvement comprising, for the purpose of excluding the sub-unit M, adding to the reaction mixture comprising determination reagents and the creatine kinase-containing sample, monovalent fragments obtained from antibodies against the sub-unit M by proteolytic cleavage under reducing conditions.
[US4330620A]
Patent IE-37292-L (IE)
Title: Mineral salt preparation
IPC: A61K33/14
Filed: 1973-02-19
Abstract: 1356097 Mineral salt preparations F HOFFMANNLA ROCHE & CO AG 23 Feb 1973 [25 Feb 1972] 9054/73 Heading A5B Mineral salt preparations having delayed electrolyte release for the continuous replacement of mineral salts lost by bodily stress and increased transpiration as well as by the use of diuretics, comprises a matrix suitable for imparting slow-release characteristics and in the form of salts 5 to 80 parts by weight of calcium, 5 to 40 parts by weight of magnesium. 2 to 20 parts by weight of potassium and no sodium of less than 20 parts by weight of sodium; the calcium, magnesium and sodium constituting more than 10% by weight of the preparation. The salts may be the appropriate halides, sulphates, phosphates, glycerophosphates, tartrates, citrates or ascorbates. A preferred preparation contains calcium and magnesium glycerophosphates and sodium and potassium chlorides. The preparations may be administered orally in the form of tablets, drage s or capsules and may also contain vitamins C, B 1 and B 6 and/or citric acid. The tablets may have a matrix of natural or synthetic material such as wax, e.g. hardened castor oil.
[GB1356097A]
Patent IE-38941-L (IE)
Title: 3-oxoglutaric acid and citric acid.
IPC: C07C67/00
Filed: 1974-02-28
Abstract: A feasible process for the production of 3-oxoglutaric acid is disclosed wherein ketene and phosgene are reacted in a molar ratio of ketene to phosgene of less than 2 in an organic solvent possessing a dielectric constant at 20 DEG C between 2 and 22 and reacting the resulting product with a Zerewitinoff active hydrogen compound.
[US3963775A]
Patent IE-35064-L (IE)
Title: Ceramic preform for semiconductors
IPC: H01L23/31
Filed: 1971-04-16
Abstract: 1356061 Semi-conductor devices GENERAL ELECTRIC CO 24 May 1971 [22 May 1970] 16755/71 Heading H1K A Si wafer having a junction extending to a peripheral edge surface is mounted within a ceramic (or glass) preform having a surface conforming to the edge surface to which it is secured by means of a layer of glass passivant less than 1 mil. thick. The preform has a coefficient of expansion substantially matching that of Si and the passivant has a coefficient of expansion greater than that of Si but less than 45 x 10<SP>-7</SP>/C. and a firing temperature below that of the preform. As shown, Fig. 1, the bevelled edge 13 of a Si rectifier is coated with a soft glass frit, the wafer is fitted into a matching aperture 17 in a preform 15 and the assembly is fired to form a glass passivant layer 19 less than 1 mil. thick. The preform may be a crystalline or a vitreous ceramic (e.g. borosilicate or aluminosilicate glass) or may comprise a glazed ceramic. Contacts are applied by vapour depositing or sputtering on to the Si surfaces and electrodes are soft soldered to the contacts. Alternatively plates of W or Mo may be soft or hard soldered to the wafer and the surrounding surface of the preform. In a modification, Fig. 3 (not shown), the electrodes are the same size as the respective surfaces of the wafer to which they are bonded, the preform is shaped to fit the assembly and is bonded to the electrodes as well as to the edge of the wafer by a layer of glass passivant less than 1 mil. thick. An SCR, Fig. 4 (not shown), may be mounted as in the first embodiment but an aperture is provided in one main electrode for the gate lead. This lead is insulated and the exposed wafer surface is protected by filling the aperture with silicone resin or varnish, a fluorocarbon resin, or a hard glass. Alternatively a small ceramic preform surrounding and bonded to the gate lead is sealed to the wafer and the main electrode by a layer of soft glass passivant, Fig. 5 (not shown). The semi-conductor device may also be a disc, a Schottky diode or a transistor.
[GB1356061A]
Patent IE-860568-L (IE)
Title: Polyprenyl compounds
IPC: C07C63/64
Filed: 1986-03-04
Abstract: Novel polyprenyl compounds terminated with a group of 
<CHEM>
 in which X, m, and R are as defined in the specification, processes for preparing them, pharmaceutical composition containing them, and use of them for the preparation of a medicament having antihypercholesterolemic activity for the treatment of arteriosclerosis are described.
Patent IE-35442-L (IE)
Title: Shift register stages
IPC: G11C19/28
Filed: 1971-07-06
Abstract: An insulated-gate field-effect transistor (IGFET) shift register stage occupies less semiconductor chip area because a separate ground lead to the gate and drain electrodes of a pair of IGFET load devices is eliminated. This lead is eliminated by substituting therefor a connection from those devices to a first clock phase which controls conduction through that pair of load devices and through a pair of cross-coupling transistors. A second clock phase, which is out of phase with the first clock phase, controls conduction through both an input transistor of the stage and a third IGFET load device connected to an output terminal of the stage.
[US3668438A]
Patent FI-820841-L (FI)
Inventor: WADSWORTH LARRY CLIFTON
IPC: H01G7/02
Filed: 1982-03-11
Abstract: A process of manufacturing an electrostatically charged filtration medium is disclosed. A web made of nonconductive thermoplastic fibers is contacted on each side with a more conductive web to form a combined web. The combined web is charged with electrically charged particles from corona charging elements on oppposite sides of the web. The charging elements are operated at a voltage of from 5 to 25 kV but with opposite polarity.
Patent FI-844075-L (FI)
Inventor: SALANSKY WERNER
IPC: A63B69/40
Filed: 1984-10-16
Abstract: In an installation for the transport of tennis balls (17) from a collector gutter to a collector container by passing through a pipe, there is provided a blower installed close to the gutter inlet end to produce a compressed air difference in the gutter; the mechanical transport installation comprises a bucket wheel (14) acting in the cross section of the gutter, and the bucket wheel (14) together with a shaft (27) parallel to the gutter (15) is arranged in a casing (23), at least two buckets preventing each time the air flow produced by the blower to come out of the casing (23).
Patent FI-851747-L (FI)
Inventor: STEEN CONRAD
IPC: D21F1/02
Filed: 1985-05-02
Abstract: A paper stock diffuser system employing a plurality of spaced, generally V-shaped projections (30) having adjoining shear surfaces (40, 42, 44, 46) diverging away from one another.
Patent FI-853719-L (FI)
Inventor: WICK ALEXANDER
IPC: C07D491/04
Filed: 1985-09-26
Abstract: Compounds of general formula (I)    <IMAGE>  (I)  wherein R1 represents a phenyl, halophenyl, methylphenyl, ethylphenyl, methoxyphenyl, trifluoromethylphenyl or naphthyl group, R2 represents hydrogen or a methyl or phenyl group, and R3 represents hydrogen or a benzyl group, except compounds in which R1 is a phenyl or 4-fluorophenyl group, R2 is hydrogen and R3 is hydrogen or a benzyl group, and their pharmaceutically acceptable acid addition salts have useful anti-depressant and anti-ischaemic properties.